Artelo Biosciences, Inc.
ARTL
$1.92
$0.2716.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.14% | -35.79% | 37.22% | -233.75% | 53.47% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 53.70% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 130.19% | -20.50% | 13.64% | 14.29% | 24.19% |
| Change in Net Operating Assets | -133.16% | 333.74% | -44.44% | 417.50% | -18.70% |
| Cash from Operations | -580.54% | 67.81% | 37.79% | -229.95% | 62.29% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -88.24% | 142.86% |
| Cash from Investing | -- | -- | -- | -88.24% | 142.86% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 219.18% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 89.65% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -333.33% | 260.00% | 155.56% | -325.00% | 500.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -126.21% | 182.91% | 21.15% | -158.08% | 1,207.01% |